211 related articles for article (PubMed ID: 12516042)
1. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
2. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
3. [Mistletoe in the treatment of cancer].
Bruseth S; Enge A
Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
[TBL] [Abstract][Full Text] [Related]
4. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
6. [Mistletoe therapy in cancer treatment: pros and cons].
Wiebelitz KR; Beer AM; Heinrich B
MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
[No Abstract] [Full Text] [Related]
7. Cytotoxic effect of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin.
Sabová L; Pilátová M; Szilagyi K; Sabo R; Mojzis J
Phytother Res; 2010 Mar; 24(3):365-8. PubMed ID: 19610041
[TBL] [Abstract][Full Text] [Related]
8. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
9. The preclinical and clinical activity of aviscumine: a potential anticancer drug.
Zwierzina H; Bergmann L; Fiebig H; Aamdal S; Schöffski P; Witthohn K; Lentzen H
Eur J Cancer; 2011 Jul; 47(10):1450-7. PubMed ID: 21482461
[TBL] [Abstract][Full Text] [Related]
10. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Kelter G; Schierholz JM; Fischer IU; Fiebig HH
Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
[TBL] [Abstract][Full Text] [Related]
12. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
15. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
16. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
[TBL] [Abstract][Full Text] [Related]
17. [Value of mistletoe therapy in carcinoma patients].
Rostock M; Unger C
Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
[No Abstract] [Full Text] [Related]
18. [Mistletoe in cancer treatment].
Umbreit D
Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S13-5. PubMed ID: 21452100
[No Abstract] [Full Text] [Related]
19. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
Melzer J; Iten F; Hostanska K; Saller R
Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
